echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > PNAS: The secret of new coronavirus spreading between cells

    PNAS: The secret of new coronavirus spreading between cells

    • Last Update: 2022-01-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A new study found that the new coronavirus has taken some secret actions to survive, and one of its secrets to success is to escape from the immune system through cell-to-cell transmission
    .

    Cell culture experiments show that SARS-CoV-2, which causes COVID-19, restricts the release of virus particles that can be inactivated by antibodies.
    They are hidden in the cell wall and spread between cells
    .

    "This is basically a form of underground transmission," said lead author Shan-Lu Liu, a professor of virology in the Department of Veterinary Biological Sciences at Ohio State University and a researcher at the University's Retroviral Research Center
    .

    "SARS-CoV-2 can effectively spread between cells because there is basically no blocker from host immunity
    .


    The target cell becomes a donor cell, and then it completes a wave of transmission


    Liu and colleagues also discovered some other enlightening details about SARS-CoV-2: The spike protein on the surface of the virus can achieve cell-to-cell transmission, but the virus's main receptor on the target cell-the spike Binding to target cells-not a necessary part of cell-to-cell propagation operations
    .


    In addition, they also found that when the virus spreads through cells, neutralizing antibodies are less effective against the virus


    The research was published in the December 22 issue of PNAS
    .

    One of the main points of this study is to compare SARS-cov -2 with the coronavirus after the SARS outbreak in 2003
    .


    He said: "This finding helps explain why the first epidemic lasted only 8 months, resulting in a much higher mortality rate, and we are about to exceed the current two-year record of the epidemic, and most of the cases are asymptomatic.


    Research comparisons have shown that the mode of transmission of SARS in 2003 is different from SARS-CoV-2.
    The former is when free-floating virus particles infect target cells by binding to a receptor surface (still susceptible to antibodies produced by previous infections and vaccines)
    .


    SARS-CoV-2 is more effective in spreading between cells, which makes it more difficult to be neutralized by antibodies


    The different efficacies of these two viruses were first demonstrated in experiments using pseudoviruses
    .


    Pseudovirus is a non-infectious virus core decorated with two coronavirus spike proteins


    "For the intercellular transmission of SARS-CoV-2 and SARS-CoV, the spike protein is necessary and sufficient, because the only difference between these pseudoviruses is the spike protein
    .


    "

    Studying these differences more deeply, the researchers found that SARS-CoV-2 is also more capable than SARS-CoV in initiating fusion with the target cell membrane, which is another key step in the virus entry process
    .


    This stronger fusion effect is related to the enhanced cell-to-cell transmission of the virus


    Liu also found that the paradox is that too much cell membrane fusion can cause cell death, which actually interferes with cell-to-cell transmission
    .

    Subsequently, the research team turned to the role of ACE2 receptors
    .


    The ACE2 receptor is a protein on the surface of cells and is the gateway for the virus that causes COVID-19 to enter


    "There is no perfect correlation between SARS-CoV-2 infection and ACE2 levels," Liu said.
    "The initial infection may require ACE2, but once the infection is established, the virus may no longer require ACE2 because it can spread between cells
    .


    "

    Finally, in the experiment of real SARS-CoV-2 virus detection on the blood samples of human COVID-19 patients, the researchers determined that the virus can evade the antibody response through cell-to-cell transmission, but in the cell-free mode of transmission, the antibody is And the virus is effective
    .

    "We were able to confirm that cell-to-cell transmission is not sensitive to the suppression of antibodies from COVID patients or vaccinated people.
    With the continuous emergence of SARS-CoV-2 variants, including the recent variant Omicron, cell-to-cell transmission is more effective for antibody neutralization.
    Drug resistance may be something we should pay attention to
    .
    In this sense, the development of effective antiviral drugs for other steps of viral infection is crucial
    .
    "

    There are still many unknown factors, including the exact mechanism of virus transmission between cells, how this may affect the individual's response to virus infection, and whether efficient cell-to-cell transmission will lead to the emergence and spread of new mutations
    .
    This laboratory plans to use real viruses and human lung cells to conduct more studies to further explore these issues
    .

    Original title:

    SARS-CoV-2 spreads through cell-to-cell transmission https://pubmed.
    ncbi.
    nlm.
    nih.
    gov/34937699/

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.